Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

NCT07041112 · clinicaltrials.gov ↗

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Psoriatic Arthritis (PsA)
Cardiovascular Risk Factors
Metabolic Syndrome (MetS)
Drug Survival
Pharmacogenetics

Interventions

DRUG: Biologic therapy for psoriasis

Sponsor

Juan Ruano Ruiz

Collaborators

[object Object]
[object Object]
[object Object]